CD8A and prostate cancer: Luo et al. [92] observed an upregulation of M1 macrophages and CD8+ lymphocytes expressing IFN-γ and GZMB, concluding that A. muciniphila-EVs stimulate anti-tumor immunity against prostate cancer.